
Bayer AG
XETRA:BAYN

Intrinsic Value
The intrinsic value of one
BAYN
stock under the Base Case scenario is
113.63
EUR.
Compared to the current market price of 21.03 EUR,
Bayer AG
is
Undervalued by 81%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
Bayer AG
Fundamental Analysis


Revenue & Expenses Breakdown
Bayer AG
Balance Sheet Decomposition
Bayer AG
Current Assets | 34.4B |
Cash & Short-Term Investments | 8.5B |
Receivables | 12.5B |
Other Current Assets | 13.5B |
Non-Current Assets | 76.4B |
Long-Term Investments | 3.1B |
PP&E | 13.5B |
Intangibles | 52.1B |
Other Non-Current Assets | 7.7B |
Free Cash Flow Analysis
Bayer AG
EUR | |
Free Cash Flow | EUR |
Earnings Waterfall
Bayer AG
Revenue
|
46.6B
EUR
|
Cost of Revenue
|
-21.3B
EUR
|
Gross Profit
|
25.3B
EUR
|
Operating Expenses
|
-21.3B
EUR
|
Operating Income
|
4B
EUR
|
Other Expenses
|
-6.5B
EUR
|
Net Income
|
-2.6B
EUR
|
BAYN Profitability Score
Profitability Due Diligence
Bayer AG's profitability score is 48/100. The higher the profitability score, the more profitable the company is.

Score
Bayer AG's profitability score is 48/100. The higher the profitability score, the more profitable the company is.
BAYN Solvency Score
Solvency Due Diligence
Bayer AG's solvency score is 30/100. The higher the solvency score, the more solvent the company is.

Score
Bayer AG's solvency score is 30/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
BAYN Price Targets Summary
Bayer AG
According to Wall Street analysts, the average 1-year price target for
BAYN
is 27.59 EUR
with a low forecast of 22.22 EUR and a high forecast of 38.85 EUR.
Dividends
Current shareholder yield for BAYN is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
BAYN
stock under the Base Case scenario is
113.63
EUR.
Compared to the current market price of 21.03 EUR,
Bayer AG
is
Undervalued by 81%.